What the English source shows.
- Evidence group
- In vitro laboratory studies
- Journal
- PRESENTED AT THE INTERNATIONAL CONFERENCE ON AIDS, AUGUST 7-12, 1994
- English PDF
- Page 110
Abstract focus
Immunocal (WPC) possesses antiviral and anti-apoptotic activities which may be related to its glutathione promoting activity. A clinical trial is currently going on with children with AIDS and wasting syndrome.
Context from Dr. Gutman’s comments
Building on the promising results of earlier studies with Immunocal, these prominent researchers at McGill University designed this in-vitro cell study to determine whether Immunocal could trigger anti-viral activity by raising glutathione levels. The hypothesis was confirmed, encouraging the continuation of human studies already underway in pediatric AIDS.
How to use this study responsibly
- Read it according to its evidence group, not as a universal product promise.
- Use the English PDF to verify the abstract and commentary directly.
- For medical conditions, treatment, pregnancy, breastfeeding or medication, speak with a qualified healthcare professional.